Brucella secretory protein VceA promotes FOXO1 entry into the nucleus to shift host cell metabolism toward glycolysis Authors: Shuzhu Cao, Xinxin Han, Xingmei Deng, Jia Guo, Liangbo Liu, Yu Zhang, Maratbek Suleimenov, Tianyi Zhao, Wei Li, Jian Ding, Songsong Xie, Hui Zhang Published: 2024 ABSTRACT AbstractIncreased glycolytic metabolism is a key step in the reproduction of Brucella and the induction of brucellosis, however, little is known about how this process is regulated during infection. Forkhead box protein O1 (FOXO1) is a transcription factor that regulates energy metabolism. In this study, we employ the yeast two-hybrid system (Y2H) and immunoprecipitation (Co-IP) to reverse screen for the FOXO1 for the first time and identify interactions between FOXO1 and the Brucella secretory protein VceA. Our findings reveal that the Brucella secretory protein VceA colocalizes with FOXO1 in the cytoplasm. Additionally, we observe that infection of macrophages with Brucella abortus 2308 ( S2308) promotes FOXO1 entry into the nucleus, leading to a significant upregulation of glycolysis level in macrophage. Conversely, in a VceA mutant strain (S2308-ΔVceA), we note a significant reduction in the ability of FOXO1 to enter the nucleus, accompanied by a decrease in glycolysis level. Furthermore, Brucella interacts with FOXO1 through the secreted protein VceA, promoting the entry of FOXO1 into the nucleus and thereby altering host metabolic patterns. This study provides insights into the mechanisms by which Brucella invades host macrophages and induces unique metabolic changes. These insights may offer a novel rationale for developing metabolic therapeutic strategies for the treatment and prevention of related diseases. Keywords: Brucella abortus, VceA, FOXO1, glycolysis Introduction Brucella is a gram-negative bacterium capable of infecting humans and livestock, leading to brucellosis. It commonly presents with undulant fever, weakness, weight loss, and chronic debilitating symptoms. Abortion and infertility associated with infection can result in significant economic losses [ 1, 2] . The remarkable capacity of Brucella to persist and replicate within host macrophages underlies the establishment of chronic infection [3]. Brucella enters the host cell and undergoes a continuous cycle, progressing from endosomal Brucella-containing vacuoles (eBCVs) to replicative Brucella-containing vacuoles (rBCVs) and then to autophagic Brucella-containing vacuoles (aBCVs) [ 4, 5] . One of the principal functions of the type IV secretion system (T4SS) in Brucella is to regulate the intracellular trafficking of Brucella vacuoles within host macrophages, thereby preventing their degradation within phagolysosomes [6]. For example, BSPB interacts with the conserved oligomeric Golgi (COG) complex in host cells to facilitate the orientation of Golgi-derived vesicles toward rBCVs [7]. The T4SS effector SepA is able to eliminate the lysosomal marker LAMP-1 during the conversion of eBCV to rBCV [8]. The T4SS of Brucella can also modulate the immune response. For example, the T4SS effector VceC interacts with the host cell endoplasmic reticulum (ER) chaperone Bip, resulting in ER stress. This interaction stimulates the production of inflammatory cytokines, which leads to granuloma formation and, consequently, promotes chronic infections [9]. Intracellular Brucella may also increase glucose accessibility by regulating the activity of host cell enzymes involved in carbohydrate metabolism via the T4SS secretion system. For example, the T4SS effector BPE123 interacts with and stimulates the activity of the host cell glycolytic enzyme α-enolase. This interaction is necessary for the replication of Brucella. abortus 2308 (S2308) [10]. Specific modulation of glycolytic energy flux determines macrophage polarity. The metabolic divergence of different macrophage phenotypes is of particularly relevance to the study of intracellular infections because it can directly affect pathogen survival and is likely to be a key factor in determining disease control and progression [11]. Studies have demonstrated that Brucella abortus ( B. abortus) depends on glucose metabolites, such as lactate, for survival within the host organism [12]. Glucose is the preferred carbon source for Brucella during the chronic phase of infection in mice, when it resides in alternatively activated macrophages [11]. The wild-type virulence of Brucella strains in mice depends on pyruvate kinase (PykM), whereas gluconeogenesis depends on PpdK, which is critical for glucose catabolism [13]. Glycolysis plays a pivotal role in the pathogenesis of Brucella brucellosis. Nevertheless, the precise mechanisms by which Brucella induces alterations in glycolytic metabolism in host immune cells during infection remain largely unknown. Forkhead box protein O1 (FOXO1) is a pivotal transcription factor that plays a crucial role in the regulation of glucose and energy metabolism. In most cell types, FOXO1 moves between the nucleus and cytoplasm. It functions primarily as a transcription factor following its translocation to the nucleus, where it controls the transcription of downstream genes that regulate metabolic processes. Additionally, FOXO1 can bind to specific molecules to form co-repressor or co-activator complexes [14]. FOXO1 regulates multiple levels of systemic blood glucose and transcriptionally mediates several pathways, including gluconeogenesis, glycogenolysis, adipogenesis, and thermogenesis [15]. It binds to and promotes the transcription of glucose 6-phosphatase (G6PC) and phosphoenolpyruvate carboxykinase (PEPCK), which are key enzymes that stimulate gluconeogenesis and glycogenolysis [16]. The regulatory effect of FOXO1 on cellular energy varies among tissues; for example, FOXO1 slows the metabolic activity of endothelial cells by reducing glycolysis and mitochondrial respiration [17]. In macrophages, FOXO1 regulates macrophage function through metabolic reprogramming, with downregulation of glycolysis and upregulation of oxidative phosphorylation (OXPHOS) occurring when FOXO1 is deficient [18]. Nevertheless, the effect of FOXO1 on metabolic reprogramming during Brucella infection in macrophages remains poorly understood. Despite several studies demonstrating an increase in glycolysis in Brucella-infected macrophages, knowledge regarding the regulation of these pathways during infection remains limited. Therefore, we aimed to investigate the role of the glycolytic factor FOXO1 in regulating glycolysis during Brucella infection of macrophages. To this end, we employed the yeast two-hybrid system (Y2H) and co-immunoprecipitation (Co-IP) to screen for host proteins secreted by Brucella that interact with FOXO1, specifically the VceA protein. However, FOXO1 interacts with VceA to tilt metabolism toward glycolysis. These findings provide a theoretical basis for investigating drugs or vaccines aimed at controlling Brucella colonization and chronic infections by manipulating host metabolic patterns. Materials and Methods Strains and cDNA library The wild-type strain of Brucella abortus 2308 (S2308), the B. abortus strain 2308 VceA gene deletion strain ( B. abortus-ΔVceA), the complementary strain ( B. abortus-ΔVceA-c), and Brucella secretes protein yeast cDNA libraries were obtained from the Xinjiang Center for Animal Disease Control and Prevention. The strains were propagated in Tryptic Soy Agar (TSA) or Tryptic Soy Broth (TSB) (Difco, Detroit, USA) at 37°C in a 5% CO 2 atmosphere for a specified duration. The culture medium for Escherichia coli DH5α (TIANGEN, Beijing, China) was supplemented with 100 μg/mL ampicillin or kanamycin as required. Yeast Y2HGold (MATα) (Clontech, Mountain View, USA) was cultured on synthetic dropout (SD) plates (Pyeast, Shanxi, China). Cell culture and infection Embryonic kidney HEK293T cells and macrophage RAW264.7 cell lines were procured from the Cell Resource Center (Beijing, China). Both cell lines were cultured in Dulbecco’s modified Eagle’s medium (DMEM; Gibco, Crand Island, USA) supplemented with 10% fetal bovine serum (FBS; Gibco) at 37°C in a 5% CO 2 atmosphere. Before infection, RAW264.7 cells were seeded in culture plates at a density of 1 × 10 5 cells/mL in DMEM supplemented with 10% FBS. The cultured cells were then infected with S2308 at a multiplicity of infection (MOI) of 100:1 in DMEM supplemented with 3% FBS for 60 min at 37°C in a 5% CO 2 atmosphere. After two times wash with PBS, the infected cells were incubated with 50 μg/mL gentamicin in DMEM supplemented with 3% phosphate-buffered saline (FBS) for 45 min at 37°C in a 5% CO 2 atmosphere. The cultures were subsequently washed twice with PBS and incubated in DMEM supplemented with 10% FBS (defined as time zero) at 37°C in a 5% CO 2 atmosphere for the duration of the experiments. The compound AS1842856 (MCE, Monmouth Junction, USA) was added at a concentration of 0.2 μM before infection and maintained throughout the infestation, in accordance with the test requirements. Construction of vectors The full-length FOXO1 (NCBI: NM_019739.3) and VceA (NCBI: BAB1_1652) sequences were synthesized by Generalbiol (Hefei, China) and subcloned and inserted into the pcDNA3.1-GFP, pCMV-HA, pDsRed2-C1, pGBKT7, and pACGFP vectors (NTCC, Beijing, China) to obtain stable pcDNA3.1- FOXO1, pGBKT7- FOXO1, pCMV-HA- FOXO1, pACGFP- VceA, and pDsRed2- VceA. Cell Transfection The cells were plated on cell culture plates at a density of 1×10 7 cells/well. After the cell density reached 80%, the constructed vector was transfected into HEK293T cells via the Lipofectamine 8000 reagent (Beyotime, Shanghai, China) according to the manufacturer’s instructions. RNA extraction and RT-polymerase chain reaction (PCR) RNA was extracted via an RNeasy kit (VAZYME, Nanjing, China), and single-stranded cDNA was synthesized via a reverse transcription kit (Takara Bio, Kyoto, Japan). Real-time PCR was conducted via SYBR Green (Toyobo, Osaka, Japan) on an Applied Biosystems 7500 Sequence Detection System (Applied Biosystems, Foster City, USA). The expression of the housekeeping gene (GAPDH) was used to normalize the mRNA expression levels. Fold changes were calculated via the 2 –ΔΔCt method. Each experiment was conducted in triplicates. Primers used are listed in Supplementary Table S1. Western blot analysis The cells were lysed in RIPA buffer containing 1 mM PMSF on ice for 30 min. Following centrifugation at 13400× g and 25°C for 20 min, the protein concentrations in the samples were determined via a BCA protein assay kit (Solarbio, Beijing, China). Subsequently, 25 μg of protein was added to each lane. Proteins were separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE), transferred to polyvinylidene fluoride (PVDF) membranes via a wet transfer system. The membranes were blocked with a 5% milk solution for 3 h at 25°C, and incubated with primary antibodies at a dilution of 1:1000, including anti-FOXO1 (ab179450; Abcam, Cambridge, UK), anti-phospho-FOXO1 (ab259337; Abcam), anti-HA (ab1424; Abcam), anti-GFP (ab32146; Abcam), anti-β-actin (ab8226; Abcam), and anti-lamin A (ab264322; Abcam). After incubation with Goat Anti-Rabbit IgG H&L (ab6721; Abcam) or Goat Anti-Mouse IgG H&L (ab205719; Abcam), Protein bands were visualized via an enhanced chemiluminescence (ECL) detection system (FUSION FX, Paris, France). Confocal microscopy HEK293T cells were grown in confocal dishes and co-transfected with pDsRed- VceA, pcDNA3.1- FOXO1, or empty plasmids. Following a 24-h period of transfection, the cell culture medium was discarded, and the cell nuclei were labeled with a solution of 4′,6-diamidino-2-phenylindole (DAPI, ab104139; Abcam) in the dark. The localization of the FOXO1 and VceA proteins in HEK293T cells was observed via a Nikon C2i+ confocal microscope (Nikon, Tokyo, Japan). Yeast two-hybrid screening A Brucella-secreted protein yeast cDNA library was screened via the FOXO1 protein. The Y187 yeast strain (MATa) was used to construct the library, while the Y2HGold (MATa) strain expressed the bait protein. A new batch of the bait strain (Y2HGold (pGBKT7- FOXO1) was introduced into SD-Trp by shaking at 230–250 rpm at 30°C. The culture was subsequently centrifuged at 700 g for 5 min, and the pellet was reconstituted in 4–5 mL of SD-Trp after reaching an OD 600 of 0.8. In a sterile 2-L flask, 4–5 mL of the bait strain was combined with 1 mL of the Brucella protein library and 45 mL of 2× YPDA liquid medium containing 50 μg/mL kanamycin. The mixture was incubated at 30°C with shaking at approximately 30–50 rpm. After 20–24 h, the cells were centrifuged at 700 g for 5 min, and the resulting pellet was resuspended in 10 mL of 0.9% NaCl solution. The cells were then plated on 90-mm SD/Leu/-Trp/X--Gal/AbA plates (DDO/X/A) (Pyeast). The plates were incubated at 30°C for 3–5 days. To prevent false positives, all positive clones were eliminated by transferring them to a more rigorous medium, designated SD/-Trp/-Leu/-His/-Ade/X-Gal/AbA (QDO/X/A) (Pyeast). Co-immunoprecipitation (Co-IP) assay The pACGFP- VceA and pCMV-HA- FOXO1 plasmids were cotransfected into HEK293T cells via Lipofectamine 8000 (C0533; Beyotime). After a 24-h transfection period, the cells were treated with ice-cold nondenaturing IP lysis buffer (26149; Thermo Fisher Scientific, Waltham, USA). Co-IP was performed according to the manufacturer’s instructions. Prior to use, a rabbit anti-HA tag antibody (ab1424; Abcam) or a mouse anti-GFP antibody (ab32146; Abcam) was incubated with AminoLink Plus coupling resin for 2 h. After the resin was washed, the arterial lysates were incubated overnight at 4°C. The resin was subsequently washed once more to extract proteins via elution buffer. The Co-IP products were extracted via 5× SDS loading buffer (26149; Thermo Fisher Scientific), boiled for 10 min, and analyzed by western blot analysis. Protein-to-protein molecular docking VceA (ID: AF-O51918-F) was obtained from the UniProt database ( https://www.uniprot.org/), and the structures of the FOXO1 target proteins were homology-mode-bonded on the basis of their amino acid sequences via HDOCK ( http://hdock.phys.hust.edu.cn/). HDOCK software was used to predict binding complexes between two molecules, such as proteins and nucleic acids, via a hybrid docking strategy. The conformations with the most negative energy were selected via the scoring function and subsequently optimized via the minimization module in the MOE 2019.1 software platform to resolve the potential spatially ill-structured contacts of rigid docking. The optimization results were visualized via PyMOL 2.1 software for graphical analysis of the model. Metabolic assays The concentrations of glucose and lactate in the supernatants were quantified via colorimetric glucose assay kit (K686; BioVision, Palo Alto, USA) and lactate assay kit (K627; BioVision), respectively, according to the manufacturer’s protocols. Flow cytometry RAW264.7 macrophages were cultured in 12-well plates at a density of 1.0 × 10 6 cells/well. The macrophages were infected with S2308 or S2308-ΔVceA at a multiplicity of infection (MOI) of 100:1. The cells were collected at various time points. The mitochondrial membrane potential was determined by measuring the fluorescence of JC-1 (C2003S; Beyotime), while reactive oxygen species (ROS) production was assessed via 2′,7′-dichlorodihydrofluorescein diacetate (DCFH-DA, D6883; Sigma-Aldrich, St Louis, USA) in the FITC and PE channels, respectively, after 25 min of incubation at 37°C. Each test was conducted in triplicate. The data were analyzed via FlowJo software. Isolation of cell fractions Cytoplasmic and nuclear protein fractions were prepared as previously described [19]. Briefly, the cells were harvested and centrifuged at 700 g for 5 min. The resulting pellet was resuspended in 0.3% v/v NP-40-PBS and incubated on ice for 10 min before being subjected to centrifugation at 700 g for 5 min. The supernatant, which was collected as the cytosolic fraction, was washed twice with ice-cold 0.1% NP-40-PBS and centrifuged at 700× g for 5 min to obtain the nuclear fraction. The translocation of FOXO1 from the cytosol to the nucleus was determined by western blot analysis. Statistical analysis One-way and two-way analysis of variance (ANOVA) were employed to perform statistical analyses to determine the significance of differences between parameters via GraphPad Prism 8 software. The data are presented as mean ± standard deviation (SD). Statistical significance is indicated by P < 0.05. Results Brucella infection induces a shift in glycolysis in RAW264.7 cells This study aimed to investigate the underlying causes of metabolic reprogramming during Brucella infection. We treated RAW264.7 cells with the S2308 strain, which resulted in increased glucose consumption ( Figure 1A), sustained accumulation of extracellular lactate ( Figure 1B), and elevated expressions of proglycolytic genes, including Hk2 ( Figure 1C). This process is involved in the primary steps of glycolysis: Slc2a1, which encodes the glucose transporter GLUT1), and lactate dehydrogenase-A (LdhA), an enzyme that catalyzes lactate production during the final glycolytic step ( Figure 1C). Collectively, these findings indicated an increase in glycolysis. The Warburg effect, characterized by the transition from OXPHOS to aerobic glycolysis for energy release, is utilized by activated macrophages (M1) [20]. The proton pumps of the electron transport chain generate the mitochondrial membrane potential (ΔΨm), which is necessary for ATP production. However, ROS produced during electron transport may induce mitochondrial damage [21]. To investigate mitochondrial function, we used flow cytometry to measure functional indicators, including ROS ( Figure 1D) and ΔΨm ( Figure 1E). The results demonstrated that RAW264.7 cells infected with S2308 presented elevated levels of ROS and a reduction in the ΔΨm. These findings suggest that S2308 impairs mitochondrial function, thereby affecting energy release via OXPHOS. Our data demonstrated that S2308 induces a metabolic shift in host cells toward glycolysis. Figure 1 S2308 infection induces a glycolytic shift in RAW264.7 cells (A,B) RAW264.7 cells were infected with S2308, and cell samples were collected after 4, 12, and 24 h. Supernatants were used to determine glucose consumption and lactate production. (C) The mRNA expressions of Slc2α1, Hk2, and LdhA were detected via RT-PCR. (D,E) S2308-stimulated RAW264.7 cells were stained with DCFH-DA 2′,7′ and ROS levels were detected, or JC-1 staining was used to determine the mitochondrial membrane potential (ΔΨm) via flow cytometry. Data are shown as the mean ± SD (n = 3). *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001 (one-way ANOVA). S2308 induces FOXO1 activation and translocation FOXO1 is a multifaceted transcription factor, yet its role in Brucella infection of macrophages remains unclear. Previous studies have demonstrated that insulin induces FOXO1 activation and its translocation from the nucleus to the cytosol [22]. In this study, we treated RAW264.7 cells with the S2308 strain and measured the expressions of both FOXO1 and p-FOXO1 in cytoplasmic proteins, as well as total FOXO1 in nuclear proteins, to determine whether FOXO1 translocation from the cytosol to the nucleus occurred. As shown in Figure 2A, S2308 stimulated FOXO1 translocation from the cytosol to the nucleus in a time-dependent manner. Furthermore, S2308-stimulated FOXO1 translocation from the cytosol to the nucleus was inhibited by pretreatment with the specific FOXO1 inhibitor AS1842856. While there were no significant changes in cytoplasmic p-FOXO1, a significant decrease in nuclear FOXO1 was observed. Conversely, FOXO1 overexpression promoted FOXO1 translocation from the cytosol to the nucleus ( Figure 2B). Importantly, there was no significant difference in FOXO1 protein expression between the S2308-pcDNA3.1-infected group and the S2308-infected group. However, there was a significant difference in FOXO1 protein expression between the S2308-infected and S2308-pcDNA3.1-FOXO1-infected group, suggesting that this differential expression is associated with FOXO1 overexpression rather than with pcDNA3.1. These findings demonstrate that S2308 stimulates the activation and translocation of FOXO1 and that the inhibition of FOXO1 reduces its nuclear localization. Figure 2 S2308 induces FOXO1 activation and translocation (A) RAW264.7 cells were infected with S2308. Nuclear and cytoplasmic proteins were collected at 4, 8, 12, and 24 h. The protein expression levels of FOXO1 and p-FOXO1 in the cells were detected by western blot analysis. (B) RAW264.7 cells were infected with S2308, S2308 and pcDNA3.1-FOXO1, S2308 and pcDNA3.1, S2308 and AS1842856, and nuclear and cytoplasmic proteins were collected at 24 h. The protein expressions of FOXO1 and p-FOXO1 in the cells were detected via western blot analysis. FOXO1 drives the glycolytic shift in S2308-infected macrophages FOXO1 plays a critical role in regulating macrophage function via metabolic reprogramming [18]. Previous studies have shown that macrophages deficient in FOXO1 exhibit reduced glycolysis [18]. This study aimed to elucidate the crucial role of FOXO1 in the regulation of glucose metabolism in macrophages during S2308 infection. RAW264.7 cells were treated with either the FOXO1 inhibitor AS1842856 or a FOXO1 overexpression vector (pcDNA3.1- FOXO1) and then infected with S2308. Compared with the S2308 infection group, the AS1842856 treatment group presented a reduction in glycolytic level, whereas the pcDNA3.1- FOXO1-treated group presented a marked increase in glycolysis ( Figure 3A–C). This contrast highlights the regulatory role of FOXO1 in modulating glycolytic activity during Brucella infection. To investigate the role of mitochondria, we used flow cytometry to assess two key functional indicators, ROS ( Figure 3D) and ΔΨm ( Figure 3E). The results demonstrated that RAW264.7 cells infected with S2308 presented increased ROS levels and decreased ΔΨm ( Figure 3D,E). Compared with those in the S2308 infection group, the ROS and ΔΨm levels ( Figure 3D,E) in the AS1842856 treatment group were greater. Furthermore, following FOXO1 overexpression, both ROS and ΔΨm levels decrease, although the exact mechanism behind these changes remains unclear. Collectively, these results indicate that FOXO1 drives the shift in metabolic activity from OXPHOS to glycolysis. Figure 3 The FOXO1 pathway drives metabolic reprogramming in S2308-infected macrophages RAW264.7 cells were infected with S2308, S2308 and AS1842856, and S2308 and pcDNA3.1-FOXO1 cell samples were collected for 24 h. (A,B) Glucose consumption and lactate production were measured via a glucose assay kit and a lactate assay kit. (C) The mRNA expressions of Slc2α1, Hk2, and LdhA were detected via RT-PCR. (D,E) The ROS levels and ΔΨm were detected via flow cytometry. Data are presented as the mean ± SD (n = 3). *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001 (two-way ANOVA). Screening and validation of Brucella-secreted proteins that interact with FOXO1 To investigate the potential role of Brucella secretory proteins in glucose metabolism, we employed a yeast two-hybrid (Y2H) system to screen for Brucella secretory proteins that interact with FOXO1. The pGBKT7- FOXO1 bait plasmid was constructed ( Supplementary Figure S1), and its functionality and self-activation were analyzed ( Supplementary Figure S2). To ensure the effectiveness of the pGBKT7- FOXO1 bait in the Y2H system for membrane proteins, functional and self-activation assays were employed. The initial step in this process was to screen for Brucella-secreted proteins that interact with FOXO1. The pGBKT7- FOXO1 bait plasmid was co-transferred with pGADT7, which carries a Brucella secretory protein gene, into yeast cells, which were then cultured. All potentially positive colonies were selected on SD-Leu-Trp/X-α-Gal/AbA (DDO/X/A) and SD/-Trp/-Leu/-His/-Ade/X-α-Gal/AbA (QDO/X/A) plates ( Supplementary Figure S3A) and incubated for 3–5 days at 30°C. Yeast colonies cultured on selective media are capable of interacting with both bait and prey proteins. To minimize the number of false positives, one-to-one return plate verification of the bait and prey plasmids was performed after mating ( Supplementary Figure S3B). Upon completion of these steps, six positive clones were identified, and their details are summarized in Table 1. Table 1 List of proteins interacting with FOXO1 Name ORF in B. abortus Host target Function BPE865 BAB1_1865 Unknown Interaction with α-enolase. BSPB BAB1_0712 COG Redirects Golgi vesicular traffic; rBCV biogenesis; intracellular replication. BMCO1 BMEII0580 Unknown Brucella copper oxidase (BmcO), which mediates Brucella’s tolerance to copper ions. VceA BAB1_1652 Unknown Promotes apoptosis and inhibits autophagy in Brucella-infected human trophoblast cells. BPE005 BAB1_2005 Unknown Involved in the activation of the autophagic pathway. BSEC103 BAB1_0930 Unknown BSEC103 protein may be regulated in host intracellular endoplasmic reticulum and plays an important role during stress. Table 1 List of proteins interacting with FOXO1 Name ORF in B. abortus Host target Function BPE865 BAB1_1865 Unknown Interaction with α-enolase. BSPB BAB1_0712 COG Redirects Golgi vesicular traffic; rBCV biogenesis; intracellular replication. BMCO1 BMEII0580 Unknown Brucella copper oxidase (BmcO), which mediates Brucella’s tolerance to copper ions. VceA BAB1_1652 Unknown Promotes apoptosis and inhibits autophagy in Brucella-infected human trophoblast cells. BPE005 BAB1_2005 Unknown Involved in the activation of the autophagic pathway. BSEC103 BAB1_0930 Unknown BSEC103 protein may be regulated in host intracellular endoplasmic reticulum and plays an important role during stress. Further validation of FOXO1 with putative capture proteins A yeast two-hybrid assay was used to identify proteins that potentially interact with FOXO1. The proteins screened included BSEC103, BPE865, BSPB, BMCO1, VceA, and BPE005. To validate the interactions between these proteins and FOXO1, we constructed expression vectors for these proteins and co-transfected them with the pCMV-HA- FOXO1 vector one-to-one into HEK293 cells. Co-IP verification results showed that pCMV-HA-FOXO1 could be co-immunoprecipitated with anti-HA antibodies or anti-GFP when co-expressed with pACGFP-VceA, demonstrating an interaction between FOXO1 and VceA in the cells ( Figure 4A). Figure 4 Validation of FOXO1 with putative capture proteins FOXO1 interacts directly with VceA. (A) pACGFP-VceA, pCMV-HA-FOXO1, or empty vectors were transfected into HEK293T cells, which were used either alone or in combination. After 24 h, the cells were harvested and incubated with anti-GFP (left) or anti-HA (right) antibodies. Western blot analysis was performed with the indicated antibodies. Co-IP was performed via a 26149 kit. (B) Colocalization of FOXO1 and VceA as determined by immunofluorescence confocal microscopy. Green represents FOXO1, red represents VceA, and blue represents the nucleus. The colocalization of FOXO1 and VceA is indicated in yellow. (C) The binding mode of the VceA complex with FOXO1. (a) The backbone of the protein was rendered in a tube and colored green (FOXO1) and red (VceA); (b) VceA and FOXO1 proteins were rendered on the surface; (c) The detailed binding mode of VceA with FOXO1; yellow and gray dashes represent hydrogen bonds and hydrophobic interactions. Having established the interactions between FOXO1 and VceA, we further investigated whether FOXO1 colocalizes with VceA. To determine whether these two proteins localize within the same cellular compartment, recombinant pcDNA3.1- FOXO1 and pDsRed2-C1- VceA plasmids were constructed ( Supplementary Figures S4 and S5). These plasmids were cotransfected into HEK293T cells. As illustrated by the fluorescent dots in Figure 4B, the FOXO1 was localized to both the cytoplasm and nucleus, whereas the VceA was localized exclusively to the cytoplasm. The colocalization results demonstrated that the co-expressed FOXO1 and VceA proteins completely overlapped in the cytoplasm. Protein docking of FOXO1 and VceA was performed via HadDock 2.4 to identify effective binding sites between the two proteins. The calculated binding energy is –261.92 kcal/mol. The binding sites of the VceA protein include LYS-255, PHE-327, SER-328, VAL-364, SER-367, ILE-60, TYR-55, and other amino acid residues. Similarly, the binding sites of FOXO1 include HIS-217, ASN-213, ARG-211, SER-202, ASN-155, TYR-193, HIS-212, TRP-206, and other amino acid residues. Notably, the contact residues between the VceA and FOXO1 proteins can engage in various interactions, including hydrogen bonding and hydrophobic interactions, which can effectively improve the stability of VceA and FOXO1 protein complexes. Furthermore, the binding surface diagram of the two proteins ( Figure 4C) revealed that the surfaces of FOXO1 and VceA were well matched, facilitating stable binding interactions. These data demonstrate that Brucella secretes the protein VceA, which interacts with FOXO1. VceA promotes the entry of FOXO1 into the nucleus, which shifts metabolism to glycolysis The amino acid sites where FOXO1 binds to VceA were identified, revealing multiple sites that are susceptible to phosphorylation and acetylation, including SER, TYR, and LYS ( Figure 4C). In a previous study, we demonstrated that 2308-ΔVceA inhibits apoptosis during Brucella infection [23]. One defining characteristic of apoptosis is a reduction in the membrane potential. These results suggest that the binding of the Brucella secretory protein VceA to FOXO1 may affect the phosphorylation site of FOXO1, thereby increasing its entry from the cytoplasm into the nucleus. To confirm whether VceA promotes FOXO1 nucleation, we infected RAW264.7 cells with S2308, S2308-ΔVceA, and S2308-ΔVceA-C and collected RNA, protein, and supernatant 24 h post infection. The results of the western blot analysis demonstrated that the expression of intranuclear FOXO1 was lower in the S2308-ΔVceA group than in the S2308 group ( Figure 5A). Conversely, the expression of FOXO1 in the nucleus of the S2308-ΔVceA-C group was not significantly different from that in the S2308 group, suggesting that VceA is responsible for promoting the nuclear expression of FOXO1 ( Figure 5A). We subsequently sought to determine whether VceA influences host glycolysis and mitochondrial function via FOXO1. Compared with those in the S2308-infected RAW264.7 cells, the glucose consumption, lactate production, and expressions of glycolytic genes ( Figure 5B–D) in the S2308-ΔVceA-infected RAW264.7 cells were decreased. Compared with S2308-infected cells, S2308-ΔVceA-infected cells presented increased ROS levels ( Figure 5E) and ΔΨm level ( Figure 5F). The results from the S2308-ΔVceA-C group were consistent with those of the S2308 group. Subsequently, we further examined alterations in mitochondrial morphology in RAW264.7 cells infected with either the S2308 or S2308-ΔVceA strains. The morphology and localization of mitochondria were also observed in RAW264.7 cells infected with S2308. Compared with uninfected cells, infected cells presented a less dense distribution of mitochondria, and reduced fluorescence, which may indicate mitochondrial swelling. However, this effect was improved in cells infected with S2308-ΔVceA ( Figure 5G). Figure 5 VceA promotes entry of FOXO1 into the nucleus RAW264.7 cells were infected with S2308, S2308-ΔVceA, or S2308-ΔVceA-C, and samples were collected for 24 h. (A) Protein expressions of FOXO1 and p-FOXO1 in cells was detected by western blot analysis. (B,C) Glucose consumption and lactate production were detected via a glucose assay kit and a lactate assay kit, respectively. (D) mRNA expressions of Slc2α1,Hk2, and LdhA were detected via RT-PCR. (E,F) ROS levels and ΔΨm (samples were collected for 12 h) were detected via flow cytometry. (G) Intracellular S2308 induced morphological changes in the mitochondria of RAW264.7 cells, as detected via immunofluorescence confocal microscopy, with two fields of vision showing mitochondrial (green) and nuclear (blue) staining; scale bar: 20 μm. Data are shown as the mean ± SD (n = 3). *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001 (two-way ANOVA). Consequently, Brucella influences host metabolic programming through the interaction of the secreted protein VceA with FOXO1. This interaction appears to result in alterations in mitochondrial function and an increase in glycolytic activity within the host cells. Discussion Brucella are gram-negative, facultative intracellular bacteria that induce chronic infections in a wide range of mammals, including humans and domestic ruminants [24]. Upon entering host cells, Brucella resides in acidified phagosomal compartments known as endosomes. The lysosomal pathway is not involved in the limited interaction of eBCVs. [ 25, 26] . The acidic pH of these compartments serves as a signal to induce the expression of genes encoding the T4SS, even though there is no replication of intracellular Brucella within eBCVs [27]. T4SS-mediated secretion of effectors into the host cell alters the direction of eBCV migration within the cell, reduces eBCV interaction with lysosomes, and initiates interactions with the ER. This sequence of events culminates in the formation of rBCVs, which are slightly acidic or neutral pH zones where intracellular Brucella can persist. This is the basis of chronic infections [25]. The acidic environment and Brucella T4SS secretion system play important roles in the cyclic replication of B. abortus. Furthermore, Brucella may alter the host’s metabolic environment through Brucella-secreted proteins to increase its survival and replication and evade host immunity. The specific T4SS effector RICA not only facilitates the binding of Brucella-containing intracellular bodies to late lysosomes but also increases the acidity of these intracellular bodies [8]. The Brucella secretory protein BPE123 interacts with the host glycolytic enzyme α-enolase, which is essential for the propagation of Brucella within host cells [28]. In this study, we used FOXO1, a pivotal regulator of energy metabolism, to screen for Brucella secretory proteins that interact with it in a reverse manner. The initial substrate of the Brucella T4SS was identified as VceA, which interacts with FOXO1 to increase glycolysis and inhibit OXPHOS. B. abortus replication is not dependent on OXPHOS, and mitochondrial fragmentation does not affect Brucella replication efficiency [29]. When the OXPHOS energy-producing pathway is inhibited, host cells infected with Brucella must increase the frequency of community glucose sugars to replenish their energy supply. This not only provides a rich carbon source for Brucella to survive and replicate [11] but also increases the level of lactic acid produced by glycolysis. In addition to providing Brucella with the energy substance lactic acid, this provides a favorable acidic environment for the growth of Brucella and its intra-packet recycling. This may explain the establishment of long-term chronic infections caused by Brucella spp. Our results suggest that after Brucella infection of macrophages, the Brucella secretory protein VceA co-localizes with FOXO1 and binds stably to the cytoplasm ( Figure 4). This binding decreases phosphorylated FOXO1 in the cytoplasm and increases the level of FOXO1 in the nucleus, thereby increasing the regulation of glycolysis by FOXO1 ( Figure 2, 5). FOXO1 is a major transcription factor involved in energy metabolism and regulates glucose metabolism at multiple levels [30]. FOXO1 can regulate glucose metabolism through gluconeogenesis and glycolysis [16]. Following Brucella infection, the expressions of key genes involved in glycolysis, such as Slc2α1, Hk2, and LdhA, is significantly increased. The Slc2α1 gene encodes the glucose transporter GLUT1, which increases the cellular uptake of glucose from the extracellular compartment. Hk2 catalyzes the first step of the glycolysis pathway in the first step of the reaction of key metabolic enzymes, whereas LdhA catalyzes the conversion of pyruvic acid to lactic acid, thus increasing the glycolysis rate. Moreover, the nuclear translocation of FOXO1 can regulate the pentose phosphate pathway (PPP) through G6PD [31]. The increase in the activity of the PPP leads to increased production of erythritol, a preferred carbon source for Brucella. This, in turn, promotes Brucella growth and upregulates the expressions of major virulence factors and key enzymes involved in central metabolism [32]. In addition, the increase in the PPP increases the production of nucleotides, which are essential for the synthesis of mRNAs, long non-coding RNAs, and microRNAs. This increase in the PPP facilitates the establishment of long-term chronic infection by Brucella. VceA clearly interacts with FOXO1, and the promotion of FOXO1 nucleation may play an important role in the growth and reproduction of Brucella. Disrupting this interaction and blocking FOXO1 nucleation could be effective in preventing Brucella growth and reproduction. Compared with infection with S2308, infection with S2308-ΔVceA resulted in a significant reduction in glycolysis level in host macrophages ( Figure 5). Consequently, S2308-ΔVceA may serve as a promising vaccine candidate against Brucella infections. The regulation of FOXOs is a complex process that involves multiple mechanisms, including their expression, nuclear translocation, DNA binding, and interactions with other proteins of the FOXO family. The nuclear localization of FOXO1 is proportional to its activity, as FOXO functions primarily as a transcription factor following its translocation to the nucleus. However, it can also exert “off-target” effects by binding to other cytoplasmic proteins [33]. The impact of FOXO1 on a particular activity is not always straightforward, as its function is highly modified by post-translational modifications and interactions with other partners. In our study, we confirmed that the Brucella-secreted protein VceA interacts with FOXO1, alters its localization, and promotes the translocation of FOXO1 from the cytoplasm to the nucleus. This may be a concrete manifestation of an “off-target” effect. Protein docking of FOXO1 and VceA via HadDock 2.4 revealed efficient binding sites between the two proteins. As illustrated in Figure 4C, the binding sites on VceA include LYS-255, PHE-327, SER-328, VAL-364, SER-367, ILE-60, and TYR-55, whereas those on FOXO1 include HIS-217, ASN-213, ARG-211, SER-202, ASN-155, TYR-193, HIS-212, TRP-206, and other amino acid residues. Among these, the SER and TRY are susceptible to phosphorylation. It has been postulated that the Brucella secretory protein VceA may promote the nuclear localization of FOXO1 by interacting with FOXO1, thereby affecting the phosphorylation binding site and facilitating the dephosphorylation of FOXO1. However, this hypothesis requires further confirmation. The production of ROS is a normal byproduct of cellular functions and can be specifically generated to facilitate intracellular signaling. Mitochondria are the primary source of intracellular ROS, producing O 2 .- and H 2O 2 as byproducts of cellular energy production [34]. When cells are exposed to an extracellular source of ROS, the amount of oxygen radicals or cellular detoxification by antioxidants decreases, resulting in oxygen radical stress conditions within the cells [35]. The results of our study are consistent with those of previous studies, which demonstrated that ROS levels are significantly elevated in macrophages infected with Brucella. This finding is illustrated in Figure 1D. The long-term survival of Brucella in host cells requires evasion of the killing effect of ROS. The FOXO1 pathway appears to be the mechanism by which Brucella can resist the killing effect of ROS. FOXO transcription factors are sensors of oxidative stress. For example, H 2O 2 regulates their activity and can induce apoptosis as well as stress resistance by transmitting these stresses [36]. FOXO plays a role in the stress response by upregulating the expressions of antioxidant proteins [37]. The activation of FOXO transcription factors results in the activation of multiple genes that encode antioxidant proteins, including MnSOD, which eliminates mitochondrially generated O 2 .- [38]. Increased intracellular ROS levels contribute to the localization of FOXO1 in the nucleus, increasing its transcriptional activity [36]. FOXO1 regulates the expression of ROS scavengers, such as SOD and catalase [39]. In FOXO-deficient cells, elevated ROS levels are associated with decreased expressions of antioxidant proteins. In this study, we observed a significant increase in ROS levels in Brucella-infected macrophages. However, the ROS levels were further elevated in the S2308 and AS1842856 group ( Figure 3D), suggesting that FOXO1 plays a role in ROS regulation. Brucella facilitates the nuclear translocation of FOXO1 via the secreted protein VceA, regulating it to regulate ROS in a way that helps Brucella evade oxidative stress, thereby promoting its survival. Furthermore, FOXO1 and glycolytic metabolism are closely related to Brucella-induced brucellosis. Miscarriage is a typical feature of brucellosis, and glycolytic metabolism is tightly controlled throughout pregnancy to maintain maternal-fetal homeostasis. When glycolytic metabolism is dysfunctional, conditions such as miscarriage, pre-eclampsia and placental abruption can occur [40]. FOXO1 is an important factor in the female reproductive system, particularly in the endometrium [41]. Studies using Tie2-Cre-mediated FOXO1 knockout models have demonstrated embryonic lethality and defective vascular development, indicating that endothelial FOXO1 is crucial for embryonic development [42]. Undulant fever, another typical feature of brucellosis, is also associated with glycolytic metabolism. Some studies have proposed glucose as an energy source for thermogenesis [43]. For example, in brown fat cells, glycolysis is increased, and intracellular lactate level can increase by 3-fold to support thermogenesis [44]. Downregulating the levels of glucose transporters Glut4 and Glut1, as well as the Hk2 and pyruvate kinase (Pkm), reduces thermogenesis in brown adipocytes [45]. The m6A site on FOXO1 mRNA is demethylated by adiposity- and obesity-related genes (FTOs), leading to the upregulation of FOXO1 expression. This increase in FOXO1 level subsequently regulates gluconeogenesis and thermogenesis [46]. It is evident that FOXO1 is closely related to glycolytic metabolism and brucellosis, and the utilization of key metabolic points for the prevention and control of brucellosis requires further study of the regulatory mechanisms involved. Although several previous studies of Brucella-induced alterations in glycolytic metabolism have been reported, they have been limited to cellular studies [ 11, 12, 23] . Xavier et al. [11] demonstrated that M2-like macrophages maintain a relatively high level of intracellular Brucella replication during chronic infection. This phenotype is dependent on the metabolic reprogramming induced by PPARγ activity, which leads to increased intracellular glucose level, thereby supporting intracellular bacterial growth. Daniel M. Czyża et al. [12] showed that the induction of a Warburg shift in host metabolism by B. abortus is beneficial for the intracellular survival of B. abortus. Moreover, they also revealed that the lactate-metabolizing enzyme lactate dehydrogenase (LDH) is essential for the replication and/or survival of B. abortus in normal cells [12]. Our study also confirmed, only at the cellular level, that Brucella infection induces an increased level of glycolytic metabolism in host macrophages. Further studies involving a broader range of cells and animals are needed to validate the relationship between increased glycolytic metabolism and brucellosis. Ultimately, this knowledge could inform strategies to effectively combat brucellosis by manipulating nutrient metabolites. For example, Xia et al. [47] developed a live mutant vaccine against Toxoplasma gondii lacking LDH, which was developed by utilizing glycolytic metabolism characteristics. This may be a new direction for our efforts against brucellosis. Our findings demonstrate that Brucella infection induces a shift in macrophage metabolism from OXPHOS to glycolysis. This shift is mediated by the interaction of Brucella with FOXO1 through the secreted protein VceA, which facilitates the nucleation of FOXO1, thereby favoring glycolytic metabolism. The prevailing view of metabolism is that of a self-correcting, homeostatic system, which is a dynamic adjustment system programmed to fit the requirements for cell proliferation or meet the specific needs of each differentiated tissue as appropriate. FOXO1 appears to play an important role in regulating this dynamic equilibrium. The findings of this study provide valuable insights into the mechanisms by which bacteria invade host macrophages and cause unique metabolic changes. Further research should explore the specific molecular pathways involved in the interaction between VceA, FOXO1, and glycolysis, along with the potential for targeting these pathways for therapeutic intervention. Additionally, future studies should investigate the broader implications of these findings for understanding host-pathogen interactions and metabolic regulation in other infectious diseases. Supporting information Supplementary Data Supplementary data is available at Acta Biochimica et Biophysica Sinica online. COMPETING INTERESTS The authors declare that they have no conflict of interest. Funding Statement This work was supported by the grants from the National Natural Science Foundation of China (Nos. 32372973 and 32260870), the Scientific and Technological Tackling Plan for Key Fields of the Corps (Nos. 2024AB034, 2024AB035, and 2022DB018), the National Science and Technology Basic Resources Survey Special Project (No. 2022xjkk050203), the Tianshan Talent Support Program for Young Technology Top Talents (No. CZ004001), the Corps Five Common One Promotion Project (No. CZ003802), the Young Innovative Talent Program (No. CXPY202323), Tianchi talent Project (No. CZ004310), and the 2024 Shihezi University High-Level Talent Research Project (No. RCZK202460). References Associated Data Supplementary Materials